Richard Gowan

1.2k total citations · 1 hit paper
7 papers, 944 citations indexed

About

Richard Gowan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Richard Gowan has authored 7 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Richard Gowan's work include Chemical Synthesis and Analysis (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Melanoma and MAPK Pathways (3 papers). Richard Gowan is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Melanoma and MAPK Pathways (3 papers). Richard Gowan collaborates with scholars based in United States and United Kingdom. Richard Gowan's co-authors include Judith S. Sebolt–Leopold, Wilbur R. Leopold, Sally Przybranowski, Stephen D. Barrett, Alexander J. Bridges, Haile Tecle, Alan R. Saltiel, Keri Van Becelaere, Román Herrera and David T. Dudley and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Cancer Research.

In The Last Decade

Richard Gowan

7 papers receiving 915 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

1999 804 citations Judith S. Sebolt–Leopold, David T. Dudley et al. Nature Medicine profile →

Peers

Countries citing papers authored by Richard Gowan

Since Specialization

Citations

This map shows the geographic impact of Richard Gowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Gowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Gowan more than expected).

Fields of papers citing papers by Richard Gowan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Gowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Gowan. The network helps show where Richard Gowan may publish in the future.

Co-authorship network of co-authors of Richard Gowan

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Gowan. A scholar is included among the top collaborators of Richard Gowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Gowan. Richard Gowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles—O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase) 2008 ·Bioorganic & Medicinal Chemistry Letters ·Joseph S. Warmus, Cathlin Flamme, (unknown), Stephen D. Barrett, Alexander J. Bridges, Huifen Chen, Richard Gowan, Michael D. Kaufman, (unknown), Wilbur R. Leopold, Ronald L. Merriman, Jeffrey F. Ohren, A.G. Pavlovsky, Sally Przybranowski, Haile Tecle, (unknown), Christopher E. Whitehead, Erli Zhang	60
2	Synthesis and SAR development of PD 0325901, a potent and highly bioavailable MEK inhibitor. 2004 ·Cancer Research ·Michael D. Kaufman, Stephen D. Barrett, Cathlin Flamme, Joseph S. Warmus, (unknown), (unknown), (unknown), Haile Tecle, Judith S. Sebolt–Leopold, (unknown), Richard Gowan, Keri Van Becelaere, Ronald L. Merriman, Sally Przybranowski, Jeffrey F. Ohren, Christopher E. Whitehead, Wilbur R. Leopold, Ellen M. Dobrusin, Alexander J. Bridges	1
3	Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo breakdown → 1999 ·Nature Medicine ·Judith S. Sebolt–Leopold, David T. Dudley, Román Herrera, Keri Van Becelaere, (unknown), Richard Gowan, Haile Tecle, Stephen D. Barrett, Alexander J. Bridges, Sally Przybranowski, Wilbur R. Leopold, Alan R. Saltiel	804
4	Synergy between Anions and Farnesyldiphosphate Competitive Inhibitors of Farnesyl:Protein Transferase 1997 ·Journal of Biological Chemistry ·Jeffrey D. Scholten, Karen K. Zimmerman, (unknown), Daniele M. Leonard, Judith S. Sebolt–Leopold, Richard Gowan, Donald Hupe	13
5	C-Terminal Modifications of Histidyl-N-benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in Mice 1997 ·Journal of Medicinal Chemistry ·Dennis J. McNamara, Ellen M. Dobrusin, Daniele M. Leonard, (unknown), James S. Kaltenbronn, John Quin, Scott K. Bur, C. Thomas, Annette M. Doherty, Jeffrey D. Scholten, Karen K. Zimmerman, (unknown), Richard Gowan, (unknown), Wilbur R. Leopold, Sally Przybranowski, Judith S. Sebolt–Leopold	20
6	Structure−Activity Relationships of Cysteine-Lacking Pentapeptide Derivatives That Inhibit ras Farnesyltransferase 1997 ·Journal of Medicinal Chemistry ·Daniele M. Leonard, (unknown), (unknown), (unknown), Tomi K. Sawyer, John C. Hodges, Ti‐Zhi Su, Jeffrey D. Scholten, Richard Gowan, Judith S. Sebolt–Leopold, Annette M. Doherty	31
7	Inhibitors of farnesyl:protein transferase—A possible cancer chemotherapeutic 1996 ·Bioorganic & Medicinal Chemistry ·Jeffrey D. Scholten, Karen K. Zimmerman, (unknown), Judith S. Sebolt–Leopold, Richard Gowan, Daniele M. Leonard, Donald Hupe	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact